Medication info
Donepezil Tablets 10 mg (Donepezil Hydrochloride)

Donepezil Tablets 10 mg (Donepezil Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›10.43mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 201406044 · Approved 2014.12.24 · Insurance code 622802260

Summary

Main use
Treatment of symptoms of Alzheimer's-type dementia
Who takes it
Adults · Children
Adult dose
Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil reaches steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with attention to gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs with abrupt discontinuation. Women aged 85 years or older with low body weight: Careful monitoring is necessary because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg per day.
Child dose
Children: There is no experience with use in children.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer's-type dementia

  • Symptoms of Alzheimer's dementia
View approved original text

This medication is used to improve symptoms such as memory decline and cognitive dysfunction in Alzheimer's dementia. It helps reduce difficulties experienced in daily life and enhances the overall quality of life of patients.

How to take

Adult dose

Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil reaches steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with attention to gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs with abrupt discontinuation. Women aged 85 years or older with low body weight: Careful monitoring is necessary because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg per day.

Child dose

Children: There is no experience with use in children.

Precautions

This medication contains Donepezil Hydrochloride as its active ingredient and is primarily used to treat symptoms of Alzheimer's dementia. This medication should not be used in certain patients, such as those who are allergic to this drug or similar components, pregnant or breastfeeding women, and patients with lactose intolerance or specific genetic metabolic disorders. Patients with heart disease or conduction disorders should use this medication with caution as it may slow heart rate and cause arrhythmias. Additionally, patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should be carefully administered due to the risk of gastrointestinal bleeding. Patients with asthma or obstructive pulmonary disease should be cautious as this medication can increase bronchial contraction and mucus secretion, worsening symptoms. Patients with extrapyramidal disorders such as Parkinson's disease should also be careful as this medication may exacerbate symptoms. This medication contains a colorant called Tartrazine (Yellow No. 5), and those allergic to this component must inform before use. During the use of this medication, adverse cardiac reactions such as fainting, bradycardia, heart block, myocardial infarction, and heart failure may occur, and any symptoms should be immediately discussed with healthcare providers. Serious adverse reactions such as gastrointestinal bleeding, liver dysfunction, cerebral hemorrhage, seizures, movement disorders, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and unexplained sudden death may also occur rarely. Additionally, various side effects have been reported, including nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, hallucinations, aggressive behavior, anxiety, drowsiness, headache, fatigue, rash, myalgia, and urinary incontinence, so any unusual symptoms should be reported to healthcare providers. This medication is not approved for use in other types of dementia or memory disorders besides Alzheimer's dementia, and treatment should be conducted under the supervision of an experienced physician. The therapeutic effects should be regularly evaluated, and if ineffective, consideration should be given to discontinuing the medication. Patients with heart disease or electrolyte abnormalities, particularly those with QT interval prolongation or taking medications that affect the QT interval, require cardiac monitoring. This medication may exacerbate peptic ulcers by promoting gastrointestinal motility and gastric acid secretion, so patients with a history of gastrointestinal diseases should be careful. It may affect the ability to drive or operate machinery, so caution is advised at the beginning of treatment or when increasing the dosage. Pregnant or breastfeeding women should not use this medication; if absolutely necessary, a careful decision should be made after consulting a specialist. This medication may interact with other drugs, particularly those that affect CYP3A4 and CYP2D6 enzymes, so caution is required when used concomitantly. Additionally, caution is necessary when combined with drugs affecting cardiac conduction, cholinergic agents, anticholinergic medications, and non-steroidal anti-inflammatory drugs. In case of overdose, severe symptoms such as nausea, vomiting, bradycardia, hypotension, respiratory depression, and seizures may occur, requiring immediate emergency treatment, and atropine can be used as an antidote. This medication should be stored out of reach of children, and transferring to another container is not recommended as it may negatively affect the quality.

Side effects

  • Syncope
  • bradycardia
  • heart block
  • prolonged QT interval
  • myocardial infarction
  • heart failure
  • peptic ulcer
  • perforated duodenal ulcer
  • gastrointestinal bleeding
  • hepatitis
Show 224 more
  • hepatic dysfunction
  • jaundice
  • cerebral seizures
  • intracerebral hemorrhage
  • cerebrovascular disorder
  • motor function disorder
  • ataxia
  • movement disorder
  • dystonia
  • tremors
  • involuntary movements
  • gait disorders
  • abnormal posture
  • speech disorders
  • akinetic mutism
  • extreme muscle rigidity
  • dysphagia
  • tachycardia
  • blood pressure fluctuations
  • sweating
  • myalgia
  • weakness
  • dyspnea
  • acute pancreatitis
  • acute renal failure
  • sudden death
  • cold
  • loss of appetite
  • hallucinations
  • agitation
  • aggressive behavior
  • anxiety disorders
  • insomnia
  • drowsiness
  • increased libido
  • excessive talkativeness
  • mania
  • nightmares
  • irritability
  • rambling
  • delusions
  • depression
  • confusion
  • apathy
  • hyperactivity
  • hypersexuality
  • dizziness
  • tremors
  • stupor
  • thoracic stiffness
  • palpitations
  • sinoatrial block
  • atrioventricular block
  • hypertension
  • hypotension
  • atrial fibrillation
  • idiopathic ventricular tachycardia
  • diarrhea
  • nausea
  • vomiting
  • abdominal disorders
  • constipation
  • salivation
  • fecal incontinence
  • rash
  • itching
  • muscle spasms
  • urinary incontinence
  • frequent urination
  • urinary retention
  • headache
  • fatigue
  • pain
  • toothache
  • facial flushing
  • malaise
  • lethargy
  • edema
  • fever
  • decreased body temperature
  • decreased hematocrit
  • leukopenia
  • anemia
  • thrombocytopenia
  • petechiae
  • abnormal dreams
  • decreased appetite
  • urogenital infection
  • increased CPK
  • dehydration
  • hyperlipidemia
  • insomnia
  • hostility
  • irritability
  • drowsiness
  • depression
  • confusion
  • emotional instability
  • personality disorder
  • eczema
  • urinary incontinence
  • abdominal pain
  • weakness
  • fungal infection
  • influenza-like illness
  • allergy
  • soft tissue infection
  • malaise
  • sepsis
  • facial edema
  • hernia
  • hypotension
  • ECG abnormalities
  • heart failure
  • constipation
  • gastroenteritis
  • fecal incontinence
  • dyspepsia
  • increased γ-GT
  • gastritis
  • dysphagia
  • periodontitis
  • gastric ulcer
  • periodontal abscess
  • abdominal distension
  • hepatic dysfunction
  • belching
  • esophagitis
  • anal bleeding
  • diabetes
  • anemia
  • leukocytosis
  • weight loss
  • peripheral edema
  • edema
  • increased LDH
  • increased alkaline phosphatase
  • hypercholesterolemia
  • hypokalemia
  • hypoglycemia
  • weight gain
  • hyperbilirubinemia
  • increased BUN
  • B12 deficiency anemia
  • cachexia
  • increased creatinine
  • gout
  • hyponatremia
  • hypoalbuminemia
  • iron deficiency anemia
  • increased AST
  • increased ALT
  • arthritis
  • arthrosis
  • bone fracture
  • arthralgia
  • leg cramps
  • osteoporosis
  • myalgia
  • anxiety
  • restlessness
  • spasms
  • transient psychotic disorders
  • gait abnormalities
  • apathy
  • delusions
  • dream disturbances
  • cerebrovascular abnormalities
  • increased salivation
  • ataxia
  • abnormal euphoria
  • vasodilation
  • cerebral hemorrhage
  • cerebral infarction
  • cerebral ischemia
  • dementia
  • extrapyramidal symptoms
  • grand mal seizures
  • hemiplegia
  • hypertonia
  • decreased motor activity
  • pharyngitis
  • pneumonia
  • increased cough
  • bronchitis
  • dyspnea
  • rhinitis
  • asthma
  • rash
  • skin ulcer
  • itching
  • psoriasis
  • skin discoloration
  • shingles
  • dry skin
  • sweating
  • urticaria
  • vesicular rash
  • conjunctivitis
  • glaucoma
  • visual disturbances
  • ear pain
  • tear abnormalities
  • urogenital infection
  • cystitis
  • hematuria
  • diabetes
  • vaginitis
  • urination disorders
  • frequent urination
  • proteinuria
  • abdominal pain
  • anxiety
  • cholecystitis
  • confusion
  • spasms
  • hallucinations
  • heart block
  • hemolytic anemia
  • hepatitis
  • hyponatremia
  • neuroleptic malignant syndrome
  • pancreatitis
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture infiltration. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.